Brussels, My Love?
State Of The Union
Good Morning Europe
The Global Conversation
Top News Stories Today
Hacker Hunter Next Level
Soul Of The South
Women Beyond Borders
Farm To Fork
Green In The City
Low Impact Living
Cry Like A Boy
Meet The Locals
Melting Pot Culture
The Star Ingredient
Depth Of Field
Here We Grow: Spain
The New Uzbekistan
A Greener Future
Digital Garden City Nation
Invest In Brazil
Under The Hood
Europe's energy crisis
More about this topic
Moderna sues Pfizer-BioNTech for copying tech behind COVID vaccines
EUROPE'S ENERGY CRISIS
More about this topic
Moderna COVID vaccine approved by EU regulator for children aged 5-11
The European Medicines Agency also recommended booster shots for children aged 12 and older.
Get ready for yearly COVID-flu combo vaccines, say Moderna and Pfizer
Vaccine maker Moderna predicted that its seasonal COVID and flu boosters would be available in some countries within the next two years.
COVID vaccines are not enough for Omicron variant, warns BioNTech CEO
"We must be aware that even triple-vaccinated are likely to transmit the disease’” Ughur Sahin said, the CEO of the German company behind the mRNA vaccine produced with Pfizer.
Here’s what COVID vaccine makers are doing about the Omicron variant
COVID vaccine manufacturers are racing to develop new doses to combat the rising number of cases connected to the Omicron variant.
EU medicines agency approves Moderna COVID-19 vaccine booster dose
The European medicines regulator said data showed a third dose of Moderna's COVID-19 vaccine led to a rise in antibody levels.
Moderna says its COVID-19 vaccine is safe and effective for kids 6-11
The company plans to submit new data to global regulators.
Denmark still offering kids Moderna jab, despite what it said earlier
Danish authorities said a Wednesday announcement seeming to restrict the use of the Moderna jab was badly worded, and that the country continued to offer under-18s the vaccine.
Sweden and Denmark halt use of Moderna vaccine in younger people
Noting it was an extremely rare side effect, the Swedish and Danish health authorities put Moderna use on hold due to the risks of heart inflammation.
Japan reports more contamination in Moderna vaccines from Spain
Japan has detected black particles in more vials of the Moderna coronavirus vaccines imported from Spain.
Two die in Japan after receiving suspended Moderna COVID vaccines
The Japanese government had suspended the Moderna vaccine earlier this week over concerns of contaminants in 1.63 million vaccine doses.
Japan suspends use of 1.63m Moderna vaccines over contamination fears
Officials have asked Moderna to conduct an emergency investigation and told medical institutions to stop using the vaccine produced in Spain.
COVID-19 booster shots already underway in several countries
Some countries are starting to offer a third dose of the COVID-19 vaccine for the most vulnerable, in an attempt to combat the spread of the Delta variant.
Pfizer and Moderna hike COVID vaccine prices amid variant fears
The Pfizer vaccine rises from €15.50 to €19.50. The price of Moderna's vaccine will increase from €19 to €21.50.
European Medicines Agency first to approve Moderna jab for children
It is the first time the vaccine has been authorised for people aged under 18.
EU says it is on target to vaccinate 70% of population by end of July
In Belgium and Malta, 71% of the population have already received one jab, but in Bulgaria, that figure is just 16%.
CDC: COVID-19 vaccines beneficial despite rare heart inflammation
U.S. health officials are strengthening cautions about a rare side effect of some COVID-19 vaccines — chest pain and heart inflammation, mostly seen in teenagers and young adults
Merkel takes Moderna as second COVID jab after first AstraZeneca dose
The German Chancellor's office confirmed that Merkel was given an injection of the Moderna vaccine on Tuesday, having received a first dose of AstraZeneca in April.
Dutch production line to increase Moderna COVID-19 jab output
This line will enable the supply of an additional 300 million doses of Moderna's booster variant vaccine candidate per year, if authorised.
Moderna says its COVID-19 jab is highly effective in 12-17 year olds
The results could pave the way for the vaccine to be made available to younger age groups.
WHO approves Moderna COVID-19 vaccine for emergency use
The American-made vaccine joins AstraZeneca, Pfizer-BioNTech and Johnson & Johnson in receiving the WHO's emergency use listing.